Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Pulmonary embolism.

Samuel Z Goldhaber1

  • 1Cardiovascular Division, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02115, USA. sgoldhaber@partners.org

Lancet (London, England)
|April 20, 2004
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Superficial Vein Thrombosis: A Review.

JAMA·2025
Same author

Apixaban for Extended Treatment of Provoked Venous Thromboembolism.

The New England journal of medicine·2025
Same author

Lipoprotein(a) and Venous Thromboembolism: Association, Causality, and Medications.

Thrombosis and haemostasis·2025
Same author

Use of Present-on-Admission Indicators to Improve Accuracy of Pulmonary Embolism Identification from Electronic Health Record Data.

Seminars in thrombosis and hemostasis·2025
Same author

Aspirin for Venous Thromboembolism Prophylaxis in Hip Fracture, Total Knee, and Hip Arthroplasty.

The American journal of medicine·2025
Same author

Non-O Blood Groups and Cardiovascular Outcomes in COVID-19: Findings From a Large Multicenter Study.

JACC. Advances·2025
Same journal

Medical compartmentalisation: a patient with chromosome 22q11.2 deletion syndrome in Japan.

Lancet (London, England)·2026
Same journal

[<sup>177</sup>Lu]Lu-edotreotide versus everolimus for gastroenteropancreatic neuroendocrine tumours (COMPETE): a phase 3, multicentre, randomised, open-label, superiority trial.

Lancet (London, England)·2026
Same journal

Research priorities for characterising Bundibugyo virus.

Lancet (London, England)·2026
Same journal

Rethinking treatment sequence in advanced gastroenteropancreatic neuroendocrine tumours.

Lancet (London, England)·2026
Same journal

Dual mobility total hip replacement in fractures: stability promotes patient confidence.

Lancet (London, England)·2026
Same journal

Dual mobility versus standard cups in total hip replacement for displaced femoral neck fractures (Duality): an international, multicentre, randomised, controlled, superiority trial.

Lancet (London, England)·2026
See all related articles

Pulmonary embolism (PE) is a serious condition that is hard to diagnose due to varied symptoms. Early risk stratification and anticoagulation are key treatments, with prophylaxis important for prevention.

Area of Science:

  • Medical research
  • Cardiovascular medicine
  • Pulmonology

Background:

  • Pulmonary embolism (PE) is a frequent cause of mortality and morbidity.
  • Diagnostic challenges arise from diverse clinical presentations and risk factors.
  • Early identification and risk stratification are crucial for effective management.

Purpose of the Study:

  • To outline the diagnostic and management strategies for pulmonary embolism.
  • To emphasize the importance of risk stratification in PE treatment.
  • To highlight preventative measures for PE.

Main Methods:

  • Review of current diagnostic tools including D-dimer testing and chest CT.
  • Discussion of risk stratification methods using echocardiography and troponin levels.

Related Experiment Videos

  • Analysis of therapeutic approaches, including anticoagulation, thrombolysis, and embolectomy.

    • Main Results:

    • D-dimer and chest CT are primary screening and imaging tests for PE.
    • Echocardiography and troponin levels help identify high-risk patients.
    • Anticoagulation is the cornerstone of PE therapy, with advanced interventions for high-risk cases.

    Conclusions:

    • Prompt risk assessment is vital for guiding PE treatment decisions.
    • Prophylactic measures are essential for preventing PE in hospitalized and surgical patients.
    • Extended prophylaxis post-discharge is recommended for high-risk individuals.